antimicrobial resistance

explore our policy work on amr

the threat of antimicrobial resistance (amr) has now been recognised globally and it is estimated that 10 million people a year will die due to antimicrobial resistance by 2050 if no urgent action is taken. explore more of the 英格兰vs美国谁会赢？ ’s policy work on antimicrobial resistance below.

knocking out amr

nap survey

in response to the uk’s latest five-year amr national action plan (nap), “confronting antimicrobial resistance”, the 英格兰vs美国谁会赢？ launched a survey to gather feedback and insights from the microbiology community regarding the content of the nap. read the full survey results here.
a roadmap for tackling amr

the 英格兰vs美国谁会赢？ is committed to engaging with policymakers and the media to communicate the expert opinion of the community. read our knocking out amr policy briefing here.
knocking out amr workshops | summary report

in january 2024, the 英格兰vs美国谁会赢？ hosted a series of solution-oriented, invite-only workshops dedicated to our priority solution areas: diagnostics, surveillance, therapeutics and vaccines. read the full workshop reports here.

consultation responses

nhs england: antimicrobial products subscription model consultation

the 英格兰vs美国谁会赢？ submitted a written response to a consultation launched by nhs england, in collaboration with the national institute for health and care excellence (nice) and the department of health and social care (dhsc), on the expansion of the piloted subscription-style payment model for antimicrobial products..
department of health and social care: antimicrobial resistance national action plan inquiry

the 英格兰vs美国谁会赢？ submitted a response to a call for evidence launched by the department of health and social care. this inquiry seeks to establish key priority areas for government intervention, and to gather expert knowledge to inform the new action plan and improve existing policies.
house of commons science and technology committee: the antimicrobial potential of bacteriophages inquiry

the 英格兰vs美国谁会赢？ submitted a response to a call for evidence launched by the house of commons science and technology committee on the antimicrobial potential of bacteriophages. the inquiry seeks to establish the strengths and weaknesses of bacteriophage therapy and identify opportunities for the uk government to adapt and improve existing policies.
evaluation of the eu antimicrobial resistance action plan

the 英格兰vs美国谁会赢？ submitted a letter in response to the public consultation for the evaluation of the commission’s communication to the european parliament and the council on the action plan against the rising threats from antimicrobial resistance (amr) (com (2011) 748).
house of commons health and social care committee: antimicrobial resistance inquiry (2018)

the 英格兰vs美国谁会赢？ submitted a written response jointly with the society for applied microbiology to the health and social care select committee’s antimicrobial resistance (amr) inquiry, which looked at what the uk amr 2013-2018 strategy has delivered and key actions and priorities for the next uk government strategy.
house of commons science and technology committee: antimicrobial resistance inquiry (2013)

the 英格兰vs美国谁会赢？ responded to the house of commons select committee on science and technology inquiry on antimicrobial resistance.

briefings

antimicrobial resistance in the uk: therapeutics and vaccines

antimicrobial resistance (amr) is an urgent and devastating global health crisis that threatens our healthcare systems, economies, the environment and animal health. microbiologists across the world are leading the way by working on new innovative solutions to amr, including developing novel therapeutics and vaccines.
antimicrobial resistance in the uk: diagnostics and surveillance

antimicrobial resistance (amr) is an urgent and devastating global health crisis that threatens our healthcare systems, economies, the environment and animal health. microbiologists across the world are leading the way by working on new innovative diagnostic solutions to amr.
a sustainable future: antimicrobial resistance policy report

the current landscape of amr research in the uk and ireland is highly active and expansive. however, the challenge is significant and some aspects of the research must be augmented in order to provide new solutions to infections caused by antimicrobial-resistant organisms.
antimicrobial resistance explainer

in 2015 the united nations (un) adopted the sustainable development goals (sdgs), a set of targets for the world to achieve by 2030. amr is a very real threat to achieving the un sdgs, particularly those associated with poverty, food production, the environment and sustainable economic growth.

position statements

lespar response to who global action plan on antimicrobial resistance (2015)

the learned society partnership on antimicrobial resistance (lespar), which comprises the 英格兰vs美国谁会赢？ , royal society of chemistry, biochemical society, society for applied microbiology, british society for antimicrobial chemotherapy and royal society of biology, published a statement in response to the approval of the world health organization global action plan on amr.

image credits

istock/niserin

istock/sweetbunfactory

istock/mykola sosiukin

istock/librededroit

istock/lucadp

istock/anyaivanova

istock/brasilnut1

istock/nicolae malancea

istock/alexraths

istock/alexey koza

istock/angelp

istock/gocmen